MedTrace Logo

Neuragen for Peripheral Diabetic Neuropathy

NCT00861952 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2015-03-17

No results posted yet for this study

Summary

The purpose of this study is to determine if the use of Neuragen (a natural health product oil rubbed into the skin) is effective at reducing pain and improving the quality of life in people with diabetic peripheral neuropathy.

Conditions

  • Diabetic Peripheral Neuropathy
  • Diabetic Neuralgia

Interventions

OTHER

Neuragen

2-3 drops applied topically 2-3 times per day as needed over a 3 month period

OTHER

Mineral oil

Ad lib use of mineral (scent and color matched to Neuragen) applied topically 2-3 times per day in 2-3 drops per application

Sponsors & Collaborators

  • Queen Elizabeth II Health Sciences Centre

    collaborator OTHER

  • The Canadian College of Naturopathic Medicine

    lead OTHER

Principal Investigators

  • Mary Lynch, MD · Dalhousie University

  • Kieran Cooley, ND · The Canadian College of Naturopathic Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00861952 on ClinicalTrials.gov